Published on: September 21, 2012
by Herald OnLine:
Successful Interim Results from Harvard Clinical Trial to be Followed by Studies at Other Key Research Centers in the U.S.
As the planet turns its attention to World Alzheimer’s Day, an emerging technology using focused computer brain exercises may offer new hope to Alzheimer’s patients and their families.
The NeuroAD system works like this: patients solve challenging computer exercises ranging from identifying colors, shapes, letters and animals to solving memory games. Simultaneously, the very same regions of the patient’s brain responsible for memory and learning receive electromagnetic stimulation, which reactivates brain cell activity.
The combined treatment may work more effectively than either would alone. It has already shown promising interim results in a clinical trial at Harvard University, following significant statistical and clinical results from studies in Israel. The NeuroAD system not only stopped patients’ symptoms from deteriorating, in some cases it actually improved patients’ cognitive performance to a greater extent than what is currently available with approved medications.
“It is a completely new and different approach, safe, noninvasive, and painless,” said Professor of Neurology Alvaro Pascual-Leone of Harvard Medical School, who directed the Harvard trial. “Tests have shown significant improvement of cognitive functions. As a result, patients’ daily activities such as taking care of themselves, speaking, and even recognizing their loved ones have improved dramatically.”
“Wherever we go, physicians are eager to hear about this new technology because nothing else is available to help patients,” said Eyal Baror, CEO of Israel-based Neuronix, the company behind the NeuroAD system. “NeuroAD is CE certified, which means centers in Europe and Asia are already using the device to great success. We are also aiming at FDA approval within the coming years. It may be a real game-changer for the management of Alzheimer’s disease.”
Developers are hoping that additional trials now set to take place at leading neuroscience centers in New York, Nevada and Arizona, in addition to continued work in Boston, will confirm these earlier findings.
Older people who report greater levels of social engagement have more robust gray matter in regions of the brain relevant in dementia, according to new research led by scientists at the University of Pittsburgh Graduate School of...
In a new study, University of Nebraska–Lincoln sociologist Marc A. Garcia explored how educational attainment can benefit cognitive health in later life, and whether there are differences in its benefits among minorities. Garcia and his co-authors...
A genetic variation in some people may be associated with cognitive decline that can’t be explained by deposits of two key proteins associated with Alzheimer’s disease, amyloid β and tau, according to a study...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.
